CF Industries (CF) Q2 2025 earnings summary

Executive summary

• Adjusted EBITDA reached $1.41 billion in H1 2025, up 16% year-over-year, with net earnings of $698 million ($4.20 per diluted share), reflecting strong operational performance and favorable global nitrogen market conditions.

• Over $800 million was returned to shareholders in H1 2025 through share repurchases and dividends, with a total of approximately $2 billion returned over the last 12 months.

• Donaldsonville CCS project launched in July 2025, capturing CO2 at expected rates, generating 45Q tax credits, and enabling premium low-carbon ammonia sales.

• Blue Point joint venture for low-carbon ammonia production is advancing, with project cost estimated at $3.7 billion and initial capital contributions made.

• Major clean energy and decarbonization initiatives progressed, including CCS at Donaldsonville and ongoing investments in scalable infrastructure at Blue Point.

Financial highlights

• Net sales for H1 2025 were $3.55 billion, up from $3.04 billion in H1 2024; Q2 2025 net sales were $1.89 billion, up 20% year-over-year.

• H1 2025 net earnings attributable to common stockholders were $698 million, up from $614 million in H1 2024; Q2 2025 net earnings were $386 million, down 8% year-over-year.

• H1 2025 adjusted EBITDA was $1.41 billion, up from $1.21 billion in H1 2024; Q2 2025 adjusted EBITDA was $761 million, up from $752 million.

• Gross margin for H1 2025 was $1.33 billion (37.3% of sales); Q2 2025 gross margin was $755 million (39.9% of sales).

• Trailing twelve months net cash from operations was $2.5 billion; free cash flow was $1.7 billion.

Outlook and guidance

• Full-year 2025 capital expenditures projected at $800–$900 million, with $300–$400 million for Blue Point joint venture.

• Gross ammonia production in 2025 projected at approximately 10 million tons.

• Management expects global nitrogen supply-demand balance to remain tight through 2025, supported by strong demand in Brazil and India and constrained supply from key regions.

• Anticipate incremental EBITDA and free cash flow north of $100 million annually from Donaldsonville CCS tax incentives and product premiums starting Q3.

• Long-term projections: $3 billion EBITDA and $2 billion free cash flow by 2030 mid-cycle.